Home
About
Overview
Sharing Data
ORCID
Help
History (62)
MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer.
Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor.
Dentinogenesis and Tooth-Alveolar Bone Complex Defects in BMP9/GDF2 Knockout Mice.
Thoracic endovascular repair as a safe management strategy for aortobronchial fistulas.
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
See All 62 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer. Cancer Med. 2013 Aug; 2(4):545-52.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Biomarkers
Carcinoma, Renal Cell
Everolimus
Female
Fluorodeoxyglucose F18
Humans
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Positron-Emission Tomography
Sirolimus
Treatment Outcome
Tumor Burden
authors with profiles
Daniel Appelbaum